NEUROPATHY ACTION FOUNDATION
EIN 20-4792248 · Neurology & Neuroscience (G96)
What they do
In 2025 The NAF Released A White Paper Titled, Clinical Trials for Neuropathy: Looking Ahead. The Paper Looks At How Clinical Trials Are Developing and Why Participation Remains A Critical Part of Discovering New Therapies. We Are Proud to Release Clinical Trials for Neuropathy: Looking Ahead, Said Dominick Spatafora, NAF Board President. This Study Helped Us Take A Closer Look At Whats Working, Whats Emerging, and How We Can Continue to Move Toward Treating and Preventing Neuropathy. The Report Explores The Categories That Trials Are Currently Underway: Medication and Biologics, Regenerative or Gene-related Therapies, Nerve-stimulation Devices, and Technology Like Virtual-reality Programs or Wearable Monitors.The Investigation Also Highlights Innovation In The Field, Including Precision Medicine, AI Tools, and New Trial Designs That May Shorten The Time It Takes to Understand Whether A Treatment Works.Despite The Promising Aspects of Neuropathic Treatments, Federal Funding is A Concer
Financial picture
About this charity
- Recognized since
- January 2006
- Location
- 1950 Old Tustin Avenue, Santa Ana, CA 92705
- County
- Orange
- In care of
- Christopher DeSantis
- Primary officer
- Christopher DeSantis, Executive Director
How to reach them
Filing and classification
- Latest tax year
- 2025
- Tax period began
- January 1, 2025
- Return type
- 990EZ
- Tax preparer
- SACRAMENTO ACCOUNTING & ADVISORY GROUP LLP
- NTEE classification
- Neurology & Neuroscience (G96)
- IRS tax category
- Neurology & Neuroscience
More public IRS record details
These are classification codes from the organization’s public nonprofit record.
- Subsection
- 03
- Affiliation
- 3
- Classification
- 2000
- Deductibility
- 1
- Foundation
- 15
- Organization
- 1